The research project titled “Identification and Reengineering of Effective Nanobodies Against SARS-CoV-2 Omicron Variant” by Mert Gur and his UC Berkeley collaborator Ahmet Yildiz was selected to be supported by the COVID-19 High Performance Computing Consortium (USA). The project is expected to contribute significantly to global research on developing drugs within the scope of the fight against the SARS-CoV-2 Omicron Variant.